Gritstone Bio Inc (NASDAQ:GRTS) does about 2.83M shares in volume on a normal day but saw 2066536 shares change hands in Tuesday’s trading. The company now has a market cap of 108.20M USD. Its current market price is $1.01, marking an increase of 5.01% compared to the previous close of $0.96. The 52 week high reached by this stock is $3.33 whilst the lowest price level in 52 weeks is $0.67.
Gritstone Bio Inc (GRTS) has a 20-day trading average at $0.8303 and the current price is -69.67% off the 52-week high compared with 50.39% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.6666 and its 200-day simple moving average is $1.8594. If we look at the stock’s price movements over the week, volatility stands at 9.93%, which increases to 10.15% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 44.34 to suggest the stock is neutral.
The consensus objective for the share price is $5.17, suggesting that the stock has a potential upside of 80.46% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 28, 2024 when JMP Securities initiated the stock to “Mkt Outperform” and issued a price target of $4. B. Riley Securities initiated its price target at $8.
Gritstone Bio Inc (GRTS) stock is up 26.25% over the week and 0.00% over the past month. Its price is -50.49% year-to-date and -59.92% over the past year.
To reach the target analysts have set, the stock logically needs to grow 80.46 percent from here.
The company has a return on investment of -92.50% and return on equity of -124.41%. The beta has a value of 0.62. Price to book ratio is 1.90 and price to sales ratio is 81.35.
